These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9592379)
1. Researchers wary of fear-based ban on lentivirus gene therapy. Fox JL Nat Biotechnol; 1998 May; 16(5):407-8. PubMed ID: 9592379 [No Abstract] [Full Text] [Related]
2. Pioneering HIV treatment would use interference and gene therapy. Check E Nature; 2005 Sep; 437(7059):601. PubMed ID: 16193002 [No Abstract] [Full Text] [Related]
3. Non-HIV lentiviral vectors: interview with Alan Kingsman. Kingsman A J Gene Med; 1999; 1(6):441-3. PubMed ID: 10753070 [No Abstract] [Full Text] [Related]
4. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. Vigna E; Naldini L J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424 [TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors for HIV disease prevention and treatment. Lemiale F; Korokhov N Vaccine; 2009 May; 27(25-26):3443-9. PubMed ID: 19201386 [TBL] [Abstract][Full Text] [Related]
9. [Ten years of gene therapy: thoughts and perspectives]. Cavazzana-Calvo M; Hacein-Bey-Abina S; Fischer A Med Sci (Paris); 2010 Feb; 26(2):115-8. PubMed ID: 20188032 [No Abstract] [Full Text] [Related]
10. Progress and problems with the use of viral vectors for gene therapy. Thomas CE; Ehrhardt A; Kay MA Nat Rev Genet; 2003 May; 4(5):346-58. PubMed ID: 12728277 [TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors for the treatment of neurodegenerative diseases. Martin-Rendon E; Azzouz M; Mazarakis ND Curr Opin Mol Ther; 2001 Oct; 3(5):476-81. PubMed ID: 11699892 [TBL] [Abstract][Full Text] [Related]
12. Biotechnology industry responds to gene therapy death. Commander H Nat Med; 2000 Feb; 6(2):118. PubMed ID: 10655080 [No Abstract] [Full Text] [Related]
13. Lentivirus vectors: difficulties and hopes before clinical trials. Kafri T Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555 [TBL] [Abstract][Full Text] [Related]
14. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease. Kim EY; Hong YB; Lai Z; Kim HJ; Cho YH; Brady RO; Jung SC Biochem Biophys Res Commun; 2004 May; 318(2):381-90. PubMed ID: 15120612 [TBL] [Abstract][Full Text] [Related]
15. Retroviral vectors for gene therapy of AIDS and cancer. Chang LJ; He J Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891 [TBL] [Abstract][Full Text] [Related]
16. The ability of current biologics law to accommodate emerging technologies. Carter MJ Food Drug Law J; 1996; 51(3):375-80. PubMed ID: 11797714 [No Abstract] [Full Text] [Related]
17. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149 [TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector. Podsakoff GM Mol Ther; 2001 Oct; 4(4):282-3. PubMed ID: 11592827 [No Abstract] [Full Text] [Related]